Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Expert Opinion on Drug Discovery|March 29, 2018
Discovery and development of varenicline for smoking cessationChloe J Jordan, Zheng-Xiong Xi
Frontiers in Neuroscience|January 31, 2022
Identification of the Risk Genes Associated With Vulnerability to Addiction: Major Findings From Transgenic AnimalsChloe J Jordan, Zheng-Xiong Xi
Neuroscience and Biobehavioral Reviews|January 7, 2019
Progress in brain cannabinoid CB<sub>2</sub> receptor research: From genes to behaviorChloe J Jordan, Zheng-Xiong Xi
Neuropharmacology|April 23, 2019
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphineChloe J Jordan, Jianjing Cao, Amy Hauck Newman, et al.
Annual Review of Pharmacology and Toxicology|January 7, 2021
New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use DisordersAmy Hauck Newman, Therese Ku, Chloe J Jordan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 13, 2020
Dissecting the Role of GABA Neurons in the VTA <i>versus</i> SNr in Opioid RewardEwa Galaj, Xiao Han, Hui Shen, et al.
Acta Pharmacologica Sinica|July 4, 2018
CB<sub>2</sub> receptor antibody signal specificity: correlations with the use of partial CB<sub>2</sub>-knockout mice and anti-rat CB<sub>2</sub> receptor antibodiesHai-Ying Zhang, Hui Shen, Chloe J Jordan, et al.
British Journal of Pharmacology|August 28, 2020
(±)VK4-40, a novel dopamine D<sub>3</sub> receptor partial agonist, attenuates cocaine reward and relapse in rodentsChloe J Jordan, Yi He, Guo-Hua Bi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 14, 2022
Cannabinoid CB1 Receptors Are Expressed in a Subset of Dopamine Neurons and Underlie Cannabinoid-Induced Aversion, Hypoactivity, and Anxiolytic Effects in MiceXiao Han, Ying Liang, Briana Hempel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 5, 2018
Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic ratsJun-Tao Gao, Chloe J Jordan, Guo-Hua Bi, et al.
Pageof 17